chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got it AGAIN, and I did have the shots/Suspected vaccination failure; Got it AGAIN, 2nd time in 5 years; Ear, face, neck, back burning; Ear, face, neck, back itching; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In December 2021, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, burning sensation and pruritus. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, burning sensation and pruritus were recovering/resolving.   It was unknown if the reporter considered the vaccination failure, shingles, burning sensation and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's sister. The age at vaccination was not reported. The patient had shingles shot. The patient had shingles again right before Christmas. The patient's ear, face, neck, back burning and itching at the same time. On the day of reporting it was starting to subside. The patient had shingles 2nd time in 5 years. The case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation was not reported. Note: In the narrative it was mentioned that the patient had shingles 2 times in 5 years. Since it is not clear if the 1st time was before or after the vaccine and considering there are no clear dates of each outbreak, only one event was coded.
On 9/18, 5 hrs after injection: Dizziness (vertigo), rapid heart beat, nausea, hot/cold, a little difficulty breathing (chest tightening) On 9/19 most symptoms have subsided, just a little dizziness remains. No treatment
according to my cardiologist I had a heart attack showing on my May 27, 2021 EKG. She states there is a heart attack showing on my September 28,2021 EKG as well. I am 57 years old and have never been told I had any reason to be concerned about heart disease. My thought is did the J&J vaccine cause the heart attack? I had the vaccine in March/April and the heart attack shows on the May EKG so I feel the timing is indicative of the vaccine being the potential cause.
nasea/passed out, came to with SOB/tight chest/pain from fingers to neck left arm(injection arm) on 4/22 about 5am to 3pm
On the 14th I had a sore throat, there was a lot of fluids going down my throat. I was very congested, coughing. It caused me to cough a lot. I had a terrible headache, lack of energy. I was confined to my bed. I couldn't eat, I was not hungry. I tried to drink fluids. I lost my taste. I was basically very sick for two weeks. My blood pressure and oxygen levels were okay. I tested negative at first but then a week later I tested positive.
Hearing issues in right ear. Pressure around ear (feels like it needs to pop). No congestion or sickness.
Immediately after the vaccination got a headache and sore arm and the next day my arm had 3 inch red bump. Also had a fever and it was 105.6 and then the fever came down. Then the next morning I had a big blister on the side of my tongue and that still remains tender in that spot. Had a headache for the next 30 days and a fever on and off since getting vaccinated.  Also is having intermittent fevers still as of today 02.23.22
Vertigo after all three dose of Pfizer covid 19 vaccine. Seen by PCP. Waiting to see neurologist
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 01-AUG-2016 the patient was vaccinated with improperly stored doses of (wistar ra 27-3) M-M-R lot # L029266 (dose and route of administration were not reported). This is one of several reports received from the same source. Additional information has been requested.
Patient had chills and felt ill night of shot. Then had red swollen injection site two days after injection. Doctor sent in prescription for BACTRIM.
pt recv vax 15JAN97 & w/in 6 to 9 hr it was reported that pt exp flu sx & the inj site was red, warm & indurated;
9pm: back ache,10pm: feeling generally ill, fever and chills started, could not warm up, teeth chattering, increased body aches 12am: all symptoms persist and headache starts, all continues until morning. 8am: feeling weak and dizzy, feeling like going to faint when standing. 10am: headache and general body aches continue. Fever gone. Extreme fatigue. These symptoms continue for 2 days.  By 3rd day, unusual pains felt on scalp, ribs and extremities. Headache gone by 3rd day, fatigue continued. Developed light red rash on face.Day 4: fatigue and random pains all over body plus scalp continue. Rash gone on face. Day 5: finally feeling well again. Took ADVIL for 4 days to try and control pain. I have had the TDAP vaccine before with NO side effects. This was BOOSTRIX TDAP. Not sure what my last one was 5 years ago. I am a very healthy, active person that exercises at least 2 hours daily. I felt that this reaction was very extreme and I will never take BOOSTRIX again.
Daughter was given MMR 10/21/02. A dose of .5 by Merck 0340M. She had a w/d after the shot. And then on 10/28/02 we noticed a rash all over her body. Then we saw hives forming on her legs and arms which were making them swollen. We rushed our daughter to the hospital that night to find that the hives and swelling had subsided which only left a rash. We're concerned that she had a reaction to the vaccination only because when she was 15 months old she received her first MMR and she had a seizure soon after. The doctors didn't think at the time it was connected to the vaccine and said it was probably a febrile seizure.
I now have a twitching face muscle in my chin.  It is not constant but happens frequently every day.
given as 3rd dose in Dtap and IPV schedule; 6 months old received Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 6-month-old female patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th November 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 9th November 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate schedule of vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate schedule of vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 06-DEC-2022 Reporter's comment: The nurse reported that a 6 month old patient received a dose of Kinrix. No symptoms reported. The reporter also stated that  DTAP and IPV was their (the patient's) 3rd dose with the Kinrix. The reporter gave consent to follow up. Additional Supportive Information: The 6 month old received a dose of kinrix, which led to inappropriate age at vaccine administration. The DTAP and IPV 3rd dose with Kinrix, which led to inappropriate schedule of vaccine administered.
Got it at 330 stayed for 30 min. By 7 that evening had a horrible headache, very tired, left haw pain, and a welt on my tongue. Blood sugar high in 300s The next day tongue was a bit better other symptoms the same and heart felt fluttery, and my left breast and center between felt like bruises and small lumps. Headache finally gone by Tuesday and sugars in high 200s but the rest is about the same. Less tired though
ARM FEELS LIKE HIT BY BASEBALL BAT; JUST ABOUT PASSED OUT; FELT FEELING HOT; DEVELOPED LACE TYPE RASH; PHYSICALLY EXHAUSTED, TIRED, FATIGUE; FEVER; FELT FREEZING COLD; SEIZURE LIKE TREMORS UNCONTROLLED; PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included genetic liver mutation, and other pre-existing medical conditions included the patient had sensitivity to blood thinner product. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 30-MAR-2021 16:00 on Right Arm for prophylactic vaccination. The batch number was not reported.  The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 22-MAR-2021, Laboratory data included: Blood test (NR: not provided) negative. On 30-MAR-2021, the subject experienced pain at injection site. On 31-MAR-2021, the subject experienced seizure like tremors uncontrolled. On 31-MAR-2021, the subject experienced felt freezing cold. On 31-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.2. On 01-APR-2021, the subject experienced felt feeling hot. On 01-APR-2021, the subject experienced developed lace type rash. On 01-APR-2021, the subject experienced physically exhausted, tired, fatigue. Laboratory data included: Body temperature (NR: not provided) 97.1. On 01-APR-2021 12:18, the subject experienced just about passed out. On 02-APR-2021, the subject experienced arm feels like hit by baseball bat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from seizure like tremors uncontrolled, and fever on 2021, and developed lace type rash on APR-2021, had not recovered from pain at injection site, and physically exhausted, tired, fatigue, and the outcome of just about passed out, felt freezing cold, felt feeling hot and arm feels like hit by baseball bat was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Headache Chills Shortness of breath/tachypnea  Chest pain Tachycardia Some nausea Temperature not measured
Patient received the Bivalent Pfizer vaccine as her first ever COVID vaccine, when she should have received a dose of the primary Pfizer vaccine. No adverse event noted so far. I notified patient I would call the manufacturer and ask for guidance on how to proceed with any future doses.
This spontaneous report was received from a physician via a company representative referring to a 14 year old female patient. The patient's concurrent conditions and medical history were not provided. In 2015, the patient was vaccinated with the first dose of GARDASIL intramuscularly (strength, lot number and expiration date were not provided). The patient's second dose of GARDASIL was in 27-MAR-2015. The patient was given unspecified vaccines concomitantly with the GARDASIL vaccine, however the date of administration for these vaccines was unknown. In March 2016, the patient experienced thrombocytopenia and easy bruising. The outcome of thrombocytopenia and increased tendency to bruise was unknown. No product quality complaint was involved. Additional information has been requested.
hard lump @ inject site & inadvertant administration are reported in a pt receiving 1 dose of flu vax on 1NOV93; pt was given fluogen therapy SC instead of ID;
Patient experiencing  pain at injection site/arm almost up to a month after the taking the vaccine. Reported to the pharmacy. Pharmacist advised patient to see a Doctor for treatment.
Pt experienced syncopal episode approx 15 seconds after receiving IM injection. After syncope occurred nurse maintained pt in tripod position, and continued attempting to arouse pt which was successful after 20 seconds.  Pt was moved via wheelchair to observation area, where vomiting x2 occurred.  Diphenhydramine 50 mg PO was administered.  EMS was called when pt being diaphoretic and pallor of the forehead and upper extremities was observed.  Pt declined transport to hospital for further evaluation.  Pt was observed for 30 minutes and left the clinic ambulatory.
no adverse effects reported; patient received VARIVAX and PROQUAD instead of VARIVAX and M-M-R II; patient received VARIVAX and PROQUAD instead of VARIVAX and M-M-R II; This spontaneous report was received from a registered nurse and refers to a 19-month-old male patient. There was no information about patient's concurrent conditions or pertinent medical history.  Concomitant therapy included sterile diluent.  On 15-APR-2019, the child patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot number R021377 with expiration date 25-JUL-2020 in the left thigh, and mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD), in the right thigh, lot not reported, (dose and route not reported for both vaccines) both vaccines for prophylaxis; instead of varicella virus vaccine live (oka/merck)(VARIVAX) and measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine  Live (M-M-R II).  No adverse effects reported.
pt recvd vax & was sleepy then eyes rolled back & was unresponsive & limp;
Redness, severe swelling, severe pain. Morphine, KEFLEX, malaise, fatigue, cellulitis. Hydrocodone/APAP-Thurs. Clindamycin-Fri. Warm compress. Hydroxyzine-Fri. Ondansetron-Fri.
Shots given Friday, Sept 15. On Saturday, 9/16, patient experienced flu-like symptoms: achy, chills.  At patient's appointment with shoulder surgeon on Monday, her arm was red, swollen and blistered.  Dr. diagnosed cellulitis and prescribed clindamycin 300mg to be taken three times a day for 5 days.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In or around 16-SEP-2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving ZOSTAVAX, the patient suffered a severe herpetic rash over the left side of his face and left eyelid and was diagnosed with herpes zoster ophthalmicus with conjunctivitis in the left eye. The patient additionally suffered from and was diagnosed with optic neuritis, which caused severe loss of vision in the left eye and was also diagnosed with pneumoconiosis. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient's symptoms have resulted in physical limitations not present prior to receiving the ZOSTAVAX. The patient also experienced mental and emotional distress due to resulting physical limitations and the seriousness of patient's condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered to be not recovered. Upon internal review, herpes zoster ophthalmicus, optic neuritis, and pneumoconiosis were determined to be medically significant. Herpes zoster ophthalmicus, optic neuritis, conjunctivitis, and pneumoconiosis was considered to be disabling. Additional information has been requested.
Approximately 9 days after injection, Existing Tinnutis (from 2008 after a bout of  Labrynthitis, and hearing loss), became extremely loud.  Previous Tinnitus fluctuates in tone, but this at least tripled the volume suddenly, and has not gone down.
Experienced those issues because of the ingredients of the vaccine; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Experienced those issues because of the ingredients of the vaccine) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 06-Dec-2022, the patient experienced IMMUNISATION REACTION (Experienced those issues because of the ingredients of the vaccine). At the time of the report, IMMUNISATION REACTION (Experienced those issues because of the ingredients of the vaccine) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.    Patient mentioned that patient would not receive any other dose in future.   No treatment information was provided.   This case was linked to MOD-2022-648041 (Patient Link).   Reporter did not allow further contact
Fever, dizziness, sore throat, headache, cough.  I asked if I would get sick and was told "No".  I had to go to emergency and Pay $150.00 co-pay.
This spontaneous report as received from a medical assistant refers to a 10 month old female patient. No medical history or drug allergies/reactions were reported. On 29-JUL-2013, the 10 month old patient was vaccinated with the 3 dose of ROTATEQ in the series, (dose and route not provided). No adverse effect reported. Additional information has been requested.
This spontaneous report as received from a certified medical assistant refers to unspecified patients of unknown age and gender. The patients' pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with doses of M-M-R II (lot number K021151 and expiration date 02-NOV-2016, lot number K005431 and expiration date 15-APR-2016, lot number K011189 and expiration date 12-AUG-2016, lot number K000737 and expiration date 16-JAN-2016, lot number K012473 and expiration date 26-AUG-2015, dose, therapy type and route of administration were not reported) which were exposed to temperatures outside of the recommended range. Concomitant therapy was not reported. No adverse experience was reported. This is one of the two reports received from the same reporter. Additional information has been requested.
had shot still got mild case/suspected vaccination failure; Rocky Mountain Spotted fever; got mild case; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shot still got mild case/suspected vaccination failure) (serious criteria GSK medically significant), rocky mountain spotted fever (Verbatim: Rocky Mountain Spotted fever) (serious criteria GSK medically significant) and shingles (Verbatim: got mild case). The outcome of the vaccination failure was unknown and the outcome of the rocky mountain spotted fever and shingles were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, rocky mountain spotted fever and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, rocky mountain spotted fever and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 24-MAR-2023 The case was received from the patient via interactive digital media. The patient had a shot but still got a mild case. At the same time patient had rocky mountain spotted fever. The patient ok. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
herpes Simplex 1 outbreak; This is a spontaneous report from a contactable physician (patient). A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL0140), intramuscularly on 17Dec2020 16:15 at left arm, at single dose, and received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1686), intramuscularly on 07Jan2021 07:15 at right arm, at single dose, all for covid-19 immunization. Medical history included covid-19 from an unknown date, the patient had covid prior vaccination, known allergies was none. There were no concomitant medications. The patient experienced herpes simplex 1 outbreak on 29Dec2020 08:00 and experienced herpes simplex 1 on 10Jan2021 13:00. Therapeutic measures were taken as a result of herpes simplex 1 outbreak (herpes simplex) and included treatment with Valtrex. The outcome of the event was recovered on an unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.
pt recvd vax & LA was burning & rapid pulse, slight redness was noted at inject site;
After the first shot, had a sharp inner pain for an hour or so just below the sternum.  Felt nauseous and lethargic after that leading up to the second shot.  After the second shot three days later on 10/17/2021 started vomiting.  This was the first time in 30 years or so for me to vomit.   Started developing level 10 pain just below sternum.  Went to emergency room then admitted to hospital after CT scan.   Diagnosed with superior mesenteric vein thrombosis.  Week-long hospital stay,  Put on IV blood thinners (Heparin) while at hospital.  Left after one week with oral blood thinner xorelto.  Follow up with hytology doctor today keeping this protocol now for 3 months.  Will do follow up CT scan then to see size of blood clot.
Patient tested positive for COVID-19 by Antibodies test on Monday 02Aug and by PCR on 04Aug; positive COVID-19 test with symptom; This is a spontaneous report from a contactable other hcp.    A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included ongoing hypertension. The patient's concomitant medications were not reported.  The patient tested positive for covid-19 by antibodies test on 02aug2021 and positive by PCR on 04aug2021. Symptoms was mild flu-like so far. The patient was exposed to virus around 30Jul2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective / COVID-19 cannot be ruled out.
In a time span of 40 minutes after been provided with the Jansen vaccine, my tongue began to felt asleep and my throat became to feel very tight. An hour after having been administer the vaccine I took 50mg of Benadryl and went to my nearest emergency room where they provided a decahedron syringe 2 hours after vaccine administration.